日本語AIでPubMedを検索
小児患者の歯内療法中の疼痛管理におけるアルチカインの有効性
The efficacy of articaine in pain management during endodontic procedures in pediatric patients.
PMID: 38689354
抄録
目的:
この試験は、小児患者の歯内療法中の疼痛管理におけるアルチカインの有効性を検討することを目的とした。
OBJECTIVE: This trial aimed to study the efficacy of articaine in pain management during endodontic procedures in pediatric patients.
方法:
無痛歯内療法を受けた小児98例を集め、無作為に対照群と観察群に分け、各群49例とした。対照群にはリドカインによる浸潤麻酔を、観察群にはアルチカインによる浸潤麻酔を行った。麻酔効果、麻酔開始時間、感覚回復時間、麻酔時間、痛みの強さ、血圧、心拍数、副反応を比較した。
METHODS: Ninety-eight children who received endodontic painless treatment were collected and randomly divided into the control group and observation group, with 49 cases in each group. The control group received infiltration anesthesia with lidocaine, and the observation group received infiltration anesthesia with articaine. Anesthesia effect, anesthesia onset time, sensory recovery time, duration of anesthesia, pain intensity, blood pressure, heart rate, and adverse reactions were compared.
結果:
観察群の麻酔有効率は対照群より高かった。麻酔開始時間および感覚回復時間は対照群より短く、麻酔時間は対照群より長く、VASスコアおよび顔面表情スコアは対照群より低かった。観察群の心拍数は対照群より低く、拡張期血圧は対照群より高かった。副作用の発現率は、観察群の方が対照群より低かった。
RESULTS: The effective rate of anesthesia in the observation group was higher than that in the control group. The anesthesia onset time and sensory recovery time were shorter, the duration of anesthesia was longer, and the VAS score and facial expression score were lower in the observation group than in the control group. The heart rate of the observation group was lower, and diastolic blood pressure was higher than those of the control group. The total incidence of adverse reactions in the observation group was lower than that in the control group.
結論:
小児の歯髄疾患治療において、アルチカインの使用はより優れた麻酔効果と迅速な麻酔開始を達成でき、患者の血圧や心拍数への影響が少ないだけでなく、痛みを和らげることができ、投薬後の安全性も良好である。臨床応用に値する。
CONCLUSION: In the treatment of dental pulp diseases in children, the use of articaine can achieve better anesthesia effect and rapid onset of anesthesia and has less impact on the patient's blood pressure and heart rate, but it also can relieve pain and has good safety after the use of medication. It is worthy of clinical application.